X
Novartis/Amgen migraine jab works in tough-to-treat patients
https://pharmaphorum.com/news/novartis-amgen-migraine-jab-works-tough-treat-patients/
migraine
Sosei see Teva pipeline cull as an opportunity
Troubled generics giant Teva is continuing the heavy pruning of its business and has cut a novel migraine drug from its pipeline.
Novartis/Amgen migraine drug reduces attacks after others fail
Aimovig notches up another late-stage trial success
Novartis/Amgen’s migraine drug excites with phase 3 data
Erenumab under review in US and EU
Alder shares slump despite migraine success
Investors concerned over strong placebo effect
Novartis files migraine drug with EMA
Erenumab could be first new treatment in a decade.
Teva plans migraine drug filing later this year
Blockbuster hopeful could launch next year if approved.
AZ sells migraine drug rights to Grunenthal for $300m
AZ says migraine outside its strategic focus.
1 2
